Ribonucleotides are frequently incorporated into DNA by DNA polymerases [1] [2] [3] [4] [5] [6] [7] [8] [9] , which is a subject of increasing interest discussed in a number of recent reviews [10] [11] [12] [13] [14] [15] . Under normal conditions, the cell can use the transient presence of these polymerases to its advantage: ribonucleotide incorporation by polymerase mu (Pol-µ) is thought to be beneficial for double-strand break repair by nonhomologous end joining 7, 16 , whereas ribonucleotide incorporation on the leading strand by Pol-ε promotes mismatch repair 17, 18 . However, failure to remove embedded ribonucleotides, i.e., the absence of RNase H2, results in genome instability 6, 8, [19] [20] [21] [22] [23] [24] [25] . This may be linked to heritable autoinflammatory disorders such as Aicardi-Goutières syndrome 21,25-27 and systemic lupus erythematosus 21 , and it could have relevance for the neurodegenerative disorder ataxia with oculomotor apraxia 1 (refs. 28,29). To map the genome-wide distribution of these embedded ribonucleotides, we developed a next-generation sequencing (NGS) method, emRiboSeq 30 , which relies on cleavage of the phosphodiester bond directly 5′ of a DNA-embedded ribonucleotide with recombinant RNase H2. In the cell, cleavage by RNase H2 initiates the removal of misincorporated ribonucleotides, which is a process termed ribonucleotide excision repair 31 . Therefore, the use of RNase H2-deficient cells is essential to allow mapping of ribonucleotides. We successfully used this approach to establish that ribonucleotide incorporation patterns in the S. cerevisiae genome are nonrandom, and to map the contribution of the replicative DNA polymerases 30 (Pol-ε, Pol-δ and Pol-α) using point mutations that alter their propensity to incorporate ribonucleotides 6, 18, 32 . In addition, we accurately identified origins of replication and termination regions at high resolution. In parallel, three other groups developed different methods to map embedded ribonucleotides, which yielded similar findings 33-36 (discussed further below).
IntroDuctIon
Ribonucleotides are frequently incorporated into DNA by DNA polymerases [1] [2] [3] [4] [5] [6] [7] [8] [9] , which is a subject of increasing interest discussed in a number of recent reviews [10] [11] [12] [13] [14] [15] . Under normal conditions, the cell can use the transient presence of these polymerases to its advantage: ribonucleotide incorporation by polymerase mu (Pol-µ) is thought to be beneficial for double-strand break repair by nonhomologous end joining 7, 16 , whereas ribonucleotide incorporation on the leading strand by Pol-ε promotes mismatch repair 17, 18 . However, failure to remove embedded ribonucleotides, i.e., the absence of RNase H2, results in genome instability 6, 8, [19] [20] [21] [22] [23] [24] [25] . This may be linked to heritable autoinflammatory disorders such as Aicardi-Goutières syndrome 21, [25] [26] [27] and systemic lupus erythematosus 21 , and it could have relevance for the neurodegenerative disorder ataxia with oculomotor apraxia 1 (refs. 28,29) . To map the genome-wide distribution of these embedded ribonucleotides, we developed a next-generation sequencing (NGS) method, emRiboSeq 30 , which relies on cleavage of the phosphodiester bond directly 5′ of a DNA-embedded ribonucleotide with recombinant RNase H2. In the cell, cleavage by RNase H2 initiates the removal of misincorporated ribonucleotides, which is a process termed ribonucleotide excision repair 31 . Therefore, the use of RNase H2-deficient cells is essential to allow mapping of ribonucleotides. We successfully used this approach to establish that ribonucleotide incorporation patterns in the S. cerevisiae genome are nonrandom, and to map the contribution of the replicative DNA polymerases 30 (Pol-ε, Pol-δ and Pol-α) using point mutations that alter their propensity to incorporate ribonucleotides 6, 18, 32 . In addition, we accurately identified origins of replication and termination regions at high resolution. In parallel, three other groups developed different methods to map embedded ribonucleotides, which yielded similar findings [33] [34] [35] [36] (discussed further below).
Overview of emRiboSeq
Here we describe the details of the emRiboSeq protocol, which could potentially be applied to any organism, although we emphasize its application to S. cerevisiae, which has a relatively compact genome. In brief, the protocol ( Fig. 1 ) includes isolation and sonication of genomic DNA followed by end repair, deoxyadenosine-tailing and ligation of fragments to adapters with a deoxythymidine overhang on one end and a nonligatable 2′,3′-dideoxycytidine on the other. To minimize the contribution of nicks or double-strand breaks to the background, pre-existing 3′-hydroxyl (3′-OH) groups are blocked using terminal transferase and 2′,3′-dideoxy-ATP (ddATP). The library of ligated fragments is then treated with RNase H2 (for emRiboSeq, or another appropriate endonuclease for EndoSeq), which generates 3′-OH and 5′-phosphate (5′-P) groups. Phosphates are removed to increase subsequent adapter ligation efficiency, followed by denaturation and annealing of single-stranded fragments to double-stranded adapters with a 3′ random hexamer overhang. This allows ligation of the adapter to only those fragments with free 3′-OH ends. A conjugated biotin molecule in the random hexamercontaining strand of the second adapter allows ligated fragments to be captured. Elution of the full-length nonbiotinylated strand is followed by second-strand synthesis to produce a library that requires only size selection before sequencing.
nucleotides, one needs to change only a single step in the emRiboSeq protocol. In EndoSeq, appropriate nicking endonucleases that selectively cleave and generate 3′-OH ends can be used in place of RNase H2. This could be applied to lesions such as apurinic/apyrimidinic (AP) sites (e.g., using AP endonuclease 1 (APE1)), embedded deoxyinosines (e.g., using Escherichia coli Endo V) or UV-induced damage such as cyclobutane pyrimidine dimers (e.g., using UV-damage endonuclease). In other cases, multiple enzymes may be needed to generate the required 3′-OH ends; for example, the detection of embedded deoxyuracil requires treatment with uracil-DNA glycosylase to generate AP sites, which can then be cleaved by AP lyase enzymes (e.g., APE1 or Endo IV). Endonucleases that generate double-strand breaks can also be used, although in this case strand-specific information is lost. We established proof of principle of the EndoSeq approach using sequence-specific endonucleases 30 . Together, emRiboSeq and EndoSeq add important tools to the molecular biology toolbox used to study DNA replication, damage and repair.
Comparison with other methods
Three other methods that allow embedded ribonucleotides to be mapped were developed independently [33] [34] [35] , highlighting the current interest in studying ribonucleotide incorporation and in vivo polymerase contributions. A useful review and comparison of all four methods (emRiboSeq 30 , HydEn-seq 33 , ribose-seq 35, 36 and Pu-seq 34 ) was done by Jinks-Robertson and Klein 37 . Whereas emRiboSeq uses enzymatic hydrolysis of embedded ribonucleotides (generating 5′-P and 3′-OH ends), the other three methods make use of alkaline hydrolysis of ribonucleotide-containing DNA (generating 5′-OH and 2′,3′-cyclic phosphates). The advantage of chemical hydrolysis is the simplicity of the procedure; a disadvantage is the fact that abasic sites are also prone to hydrolysis 38 , which may cause higher background. After hydrolysis, both emRiboSeq and ribose-seq capture the strand upstream of the nick, whereas HydEn-seq and Pu-seq capture the downstream fragment. The specific way in which these ends are captured differs for each method. HydEn-seq phosphorylates the 5′-OH ends and uses them to ligate on a first adapter; a second random hexamercontaining adapter is used for second-strand synthesis, which is followed by PCR amplification. Pu-seq uses random priming to perform second-strand synthesis in the presence of deoxyuridine (dU) triphosphate, which generates blunt ends that allow adapter ligation. The dU-containing strand is then degraded, and the original strand, which now contains adapters, is amplified. Ribose-seq initially ligates a two-sided adapter to the 5′-end of fragments and then applies circular ligation using Arabidopsis thaliana tRNA ligase, which is an enzyme that specifically allows single-stranded ligation to 2′,3′-cyclic phosphates. Subsequent degradation of linear DNA allows specific amplification of circular fragments. Each of the four methods is likely to introduce certain biases, and it would be useful to delineate these via in-depth side-byside comparison in the future. Notably, with the exception of emRiboSeq, each of these library preparation methods uses PCR preamplification, which is itself a potential source of bias.
Although these four methods achieve broadly the same outcome, the investigator may wish to consider the pros and cons of each before deciding which methodology to use. The main strengths of emRiboSeq are that it is a robust, reproducible and validated technique, and the absence of presequencing amplification means that no de-duplication is necessary during bioinformatics analysis, which results in superior read depth. In addition, the lack of preamplification also gives it the potential to be used as a quantitative method, although the precision of quantification will depend on the efficiency of all of the enzymatic steps in the library preparation (each should be performed to completion and under conditions that allow high specificity), as well as on the quality of the starting material. Figure 1 | The emRiboSeq protocol. Schematic depicting processing of ribonucleotidecontaining (red 'R') and nonribonucleotidecontaining DNA fragments. The first adapter (blue) attaches to both fragments, but only those that contain ribonucleotides will be captured for sequencing after ligation with the second adapter (pink). For EndoSeq, a different endonuclease is used in place of RNase H2 (Step 47). A, deoxyadenosine; Bio, biotinylated nucleoside; dd, dideoxynucleoside; NNNNNN, random deoxynucleotide hexamer; OH, hydroxyl; P, phosphate; T, deoxythymidine. Adapted from Reijns et al. 30 .
Potential disadvantages of our protocol are its relative length and its dependence on enzymatic cleavage, which could introduce enzyme-specific bias. In our published work, we successfully used recombinant human RNase H2 purified in our own laboratory. More recently, we also generated emRiboSeq libraries using a commercially available preparation of RNase HII (New England Biolabs). Preliminary analyses showed that these libraries produced similar data, indicating that type 2 RNase H enzymes from other sources can be used. However, careful experimental design and interpretation when using nucleases is important, and potential site-specific variation in activity and the risk of low-level contaminating nuclease activity in both commercial and laboratory-generated enzymes should be kept in mind. Optimal conditions for emRiboSeq are those under which all ribonucleotides are cleaved while nonspecific cleavage is minimized. Although the use of alkaline hydrolysis in other methods may result in the detection of sites additional to ribonucleotides (e.g., abasic residues), it will also circumvent potential problems such as sequence-specific biases in cleavage or contaminating nucleases.
Our method can be adapted for the use of endonucleases other than RNase H2 to study different noncanonical nucleotides. The EndoSeq method can be compared with excision-seq, which is an alternative method that makes use of enzymatic cleavage at modified bases to determine their genome-wide distribution 39 . However, this method requires the modifications under investigation to be present at a high enough frequency to generate sufficiently small fragments. This is not a limitation for EndoSeq, as fragment size is determined by initial sonication, although the presence of modifications at too high a frequency could be problematic, as discussed below.
Experimental design Sequencing platform. This protocol was developed using the Ion Torrent NGS platform (Life Technologies), but it can be adapted for other platforms through changes to the adapter sequences, which in our case were designed for compatibility with the capture and sequencing primers used for Ion Torrent. The optimum length of fragments in an NGS library also differs according to the platform used, and consequently the size-selection range (74-76) would also require adjustment. When our method is applied to organisms with a substantially larger genome than that of S. cerevisiae, read depth may become an issue, in which case the use of a sequencing methodology that generates larger numbers of reads will need to be considered.
EndoSeq.
Use of alternative endonucleases. When replacing RNase H2 with alternative endonucleases to determine the genomic distribution of noncanonical nucleotides other than ribonucleotides, there are several important considerations. The specificity of the endonuclease is crucial, and where possible nonspecific activity should be carefully avoided. It is therefore recommended that optimum conditions be established for Step 47. High-frequency cleavage (i.e., >1 cut every 400 bp) is not desirable, as fragments that are cleaved multiple times are likely to be lost during final size selection. In this case, partial digestion may be possible, but this is likely to introduce bias, with sites that are preferentially cleaved being overrepresented. The cleavage frequency of a particular nicking endonuclease can be assessed by alkaline gel electrophoresis of enzyme-treated DNA followed by densitometry 8, 30 .
Existing estimates of ribonucleotide incorporation rates by S. cerevisiae polymerases 5, 6, 30 mean that multiple cleavage of sonicated fragments should be a rare event in the emRiboSeq protocol, although the occurrence of closely spaced ribonucleotides at specific positions cannot be ruled out. EmRiboSeq would not detect these, with only the most 5′ site captured.
Starting material. Isolation of genomic DNA (gDNA) is performed under conditions that minimize the generation of nicks. In cases in which the endonuclease substrate is rapidly removed by endogenous processes, it will be necessary to isolate gDNA from cells in which these processes are inactive, through either genetic (knockout or knockdown) or chemical means (inhibitors). Although other, less efficient mechanisms exist for the removal of embedded ribonucleotides [40] [41] [42] , the use of RNase H2 null S. cerevisiae in emRiboSeq was shown to be sufficient to allow mapping of ribonucleotides misincorporated by replicative DNA polymerases 30 . Therefore, for similar experiments, the use of strains in which at least one of the genes encoding the RNase H2 subunits (RNH201, RNH202 or RNH203) is deleted is recommended. We have used both mid-log phase (A 600 nm = 0.5) and stationary phase cultures (A 600 nm = 5-6), with similar results.
The emRiboSeq protocol was implemented in S. cerevisiae, which offers a number of advantages including ease of genetic engineering and a small, well-defined genome. In addition, RNase H2-deficient yeast proliferates at a normal rate, unlike RNase H2 null mammalian cells, although the absence of RNase H2 activity in budding yeast does cause an increase in mutation rate and genome instability 6, 19, 24, [42] [43] [44] [45] .
If you are using gDNA from a source other than S. cerevisiae, Steps 1-15 should be replaced with an appropriate protocol for isolating gDNA in which cleavage at embedded ribonucleotides is avoided before Step 47. In our protocol, we ensure this by performing RNase treatment under high-salt conditions (Step 15). Because our protocol does not use preamplification, a large quantity of starting material is crucial; we recommend starting with 18 µg of DNA, so that 5 µg can be used as input for end repair (Step 33), although we have been successful with input amounts as low as 1 µg.
Controls.
It is recommended that control experiments be performed when this protocol is first carried out, especially when a new endonuclease is being used. These controls include the preparation of an 'endonuclease-negative' library in which endonuclease treatment (Step 47) is omitted. This should result in the absence of 3′-OH groups available for ligation to the second adapter (Steps 53-55), and therefore a lack of amplification when PCR is used to verify the quality of the library before sequencing (Steps 81-83). A 'positive' control experiment that allows the specificity of generated libraries to be estimated can be achieved through substitution of the endonuclease with one with well-defined sequence specificity. We originally performed such controls 30 using BciVI (New England Biolabs), which cleaves both strands, and the nicking endonuclease Nb.BtsI (New England Biolabs). The preparation of control libraries using sequence-specific endonucleases provides the additional advantage of enabling the bioinformatic processing of sequence data to be optimized using a library with highly predictable results. It should, however, be noted that because of the sensitivity of the EndoSeq method, even low levels of star activity can be observed. 
MaterIals
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REAGENT SETUP
 crItIcal Prepare all of the following solutions using nuclease-free water. Lysis buffer 2% Triton X-100, 1% SDS, 0.5 M NaCl, 10 mM Tris and 1 mM EDTA, pH 8.0; store it at room temperature (RT; 20-25 °C) for up to 6 months. TE buffer 10 mM Tris and 1 mM EDTA, pH 8.0; store it at RT for up to 6 months. TBE, 0.5× 44.5 mM Tris, 44.5 mM boric acid and 1 mM EDTA, pH 8.0; store it at RT for up to 6 months. NaCl Use NaCl, 0.5 M; store it at RT for up to 6 months. EtOH Use EtOH, 75% (vol/vol); store it at RT for up to 6 months. NaOAc Use NaOAc, 3 M, pH 5.2; store it at RT for up to 6 months. PEG-NaCl Use PEG 8000, 40% (wt/vol), and 1.25 M NaCl. Filter-sterilize it using a 0.22-µm filter and store it at 4 °C for up to 6 months; warm it to RT before use. Oligonucleotide annealing buffer, 5× 300 mM KCl and 250 mM Tris, pH 8.0; store it at RT for up to 6 months. RNase H2 reaction buffer, 2× (for use with recombinant human RNase H2 (ref. 46)) 120 mM KCl, 100 mM Tris-HCl, pH 8.0, 20 mM MgCl 2 , 0.02% BSA and 0.02% Triton X-100; store it at 4 °C for up to 6 months. NaOH Make up fresh 0.15 M NaOH for each use. Saline sodium citrate (SSC) 0.15 M NaCl, 0.015 M sodium citrate, pH 7.0; store it at RT for up to 6 months. Bind and wash buffer, 1× 10 mM Tris-HCl, pH 7.5, 1 mM EDTA and 2 M NaCl; store it at RT for up to 6 months. Bind and wash buffer, 2× 20 mM Tris-HCl, pH 7.5, 2 mM EDTA and 4 M NaCl; store it at RT for up to 6 months.
Double-stranded adapters Prepare the first adapter (dstrP1) by combining oligonucleotides trP1-top and trP1-bottom, and prepare the second adapter (dsA) by combining A-top and A-bottom (see Table 1 for oligonucleotide sequences). In each case, prepare 100 µl of 40 µM double-stranded adapter as follows: combine 40 µl of each single-stranded oligonucleotide (100 µM) with 20 µl of 5× oligonucleotide buffer and incubate the mixture at 95 °C for 5 min in a thermocycler before removing it and allowing it to cool gradually to RT (store it at −80 °C for up to 1 year). proceDure gDna isolation from yeast • tIMInG 2-3 h 1| Add 200 µl of lysis buffer and ~0.2 ml of glass beads to the pellet from a yeast culture (5 A 600 nm units) in a 1.5-ml tube. To isolate sufficient gDNA for a particular sample, we usually carry out Steps 1-14 with eight tubes per sample (i.e., a total of 40 A 600 nm units). These can be pooled in Step 14, and subsequent steps can be carried out for multiple samples at once, with appropriate adjustments for the larger volume. Amounts given in Steps 1-23 are for a single tube containing 5 A 600 nm units.
2|
Add 200 µl of phenol and vortex the mixture for 2 min (continuous mixing at 3,000 r.p.m.).
3|
Add 200 µl of TE buffer and vortex it for 1 min (continuous mixing at 3,000 r.p.m.).
4|
Centrifuge the mixture at 5,000g for 5 min at 4 °C.
5|
Transfer the aqueous phase to a new 1.5-ml tube, add 400 µl of phenol:chloroform:isoamylalcohol (25:24:1) and vortex for 30 s.
6|
Centrifuge the tube for 5 min at 5,000g at 4 °C.
7|
Add 400 µl of chloroform and vortex it for 30 s.
8|
Centrifuge the mixture at 5,000g for 2 min at 4 °C.
9|
Transfer the aqueous phase to a new 1.5-ml tube, add 1 ml of ice-cold 100% EtOH and mix it thoroughly by repeated inversion.
10|
Centrifuge the tube at ≥13,000g for 10 min at 4 °C, and remove the supernatant.
11|
Wash the pellet with 0.5 ml of 75% EtOH.
12|
Centrifuge the mixture at ≥13,000g for 2 min at 4 °C, and remove the supernatant.
13| Air-dry the pellet at RT.
14|
Resuspend the pellet containing total nucleic acids in 50 µl of 0.5 M NaCl.  crItIcal step Replicates can be pooled at this stage (with appropriate adjustments for the larger volume made in subsequent steps).
15| Add 1 µl of DNase-free RNase (0.5 µg/µl) and incubate it for 1 h at RT.
Dna purification 16|
Add 50 µl of AMPure XP after allowing it to equilibrate to RT for at least 5 min (1× volume).
17|
Mix it thoroughly and incubate the mixture for >1 min at RT. If necessary, centrifuge briefly (1,500g for 1 s at RT) to collect droplets.
18|
Place the mixture on a magnetic stand for >1 min. The beads will collect near the magnet, and the solution will become clear. Remove and discard the supernatant.
19|
Without removing the tube from the stand, wash the beads twice with 500 µl of 75% EtOH. Mixing can be achieved by rotation of the tube on the stand. Remove and discard the supernatant.
20|
Ensure that the beads are dry before resuspending them in the required volume and diluent, as detailed in the next step. This can take a few minutes at RT.
21|
Elute DNA in 50 µl of H 2 O by vortexing to resuspend and incubating at RT for 1 min.
22|
Using the magnetic stand to retain the beads, transfer the eluate to a new 1.5-ml tube, and then discard the beads.
23|
Measure the concentration of eluted gDNA using 1.5 µl on a NanoDrop spectrophotometer. Usually, ~3 µg of DNA can be expected per five A 600 units of culture.  crItIcal step If the gDNA is visualized on an agarose gel, an additional band, which migrates at ~4.5 kb, is present. This appears to be RNA resistant to RNase cleavage at 0.5 M NaCl, but it is sensitive to subsequent degradation by RNase A at low salt concentration.  pause poInt gDNA can be stored at −80 °C for at least 7 d (storage at −80 °C is recommended to prevent any unwanted RNase activity on embedded ribonucleotides).
sonication • tIMInG 2-3 h 24|
Prepare 300-µl aliquots of 10 ng/µl DNA in H 2 O in 1.5-ml tubes. Ideally, six aliquots (18 µg) of DNA should be sonicated per library; however, using as few as three aliquots can give enough material to proceed.
25|
Sonicate each aliquot to achieve an average length of ~400 bp using a Bioruptor Plus, according to the manufacturer's recommendations.
26|
Confirm the distribution of fragments by gel electrophoresis (Fig. 2a) . Load 10 µl per aliquot alongside a 100-bp DNA ladder on a 0.5× TBE, 1% agarose gel. Perform electrophoresis and visualize the gel using a nucleic acid stain (e.g., SYBR Gold).  crItIcal step The distribution of fragment sizes will have a strong influence on the concentration of the library after size selection. In our experience, an average length of ~400 bp can be achieved with 18 cycles of 30-s sonication and 60-s cooling on the 'high' setting; however, this is likely to require optimization in each laboratory.
27|
Once the desired distribution of fragments has been achieved, ethanol-precipitate the DNA. Assuming 290 µl per tube, add 1 µl of glycogen, 29 µl of 3 M NaOAc and 800 µl of 100% EtOH.
28|
Precipitate the mixture for 1 h at −20 °C, and then centrifuge it at ≥13,000g for 30 min at 4 °C and remove the supernatant.
29|
30|
Centrifuge the mixture at ≥13,000g for 2 min at 4 °C and remove all of the supernatant.
31| Air-dry the pellet, dissolve it and pool the pellets from all aliquots of each library in a total volume of 100 µl of H 2 O.
32|
Purify DNA by repeating Steps 16-23, using 120 µl of AMPure XP (1.2× volume) and eluting in 86.5 µl of H 2 O.  crItIcal step The large amount of small fragments generated during sonication can lead to a loss of up to 70% of the initial DNA. Although we have prepared libraries using as little as 1 µg, we recommend taking 5 µg of sonicated DNA through to the next steps. Subsequent steps, including reaction and purification conditions, as well as elution volumes, assume that 5 µg of sonicated DNA is used, and measurements should be scaled accordingly if this is not the case. 41| Incubate the mixture overnight or for at least 12 h at 16 °C.  crItIcal step Ligation for shorter times may be possible, but we have not tested this.
42| Add 17 µl of 5 M NaCl, and 22.5 µl of 40% PEG 8000, 1.25 M NaCl.  crItIcal step 1× NEBNext ligation buffer contains 6% PEG 6000, and it may therefore alter the size-selection effect; however, this nucleation procedure is sufficient to significantly deplete the adapters. Use the obtained concentration to scale subsequent reactions. Normally, 2-3 µg of DNA remains at this point.  crItIcal step Subsequent steps, including reaction and purification conditions, as well as elution volumes, assume that 2 µg of DNA is used, and measurements should be scaled accordingly if the amount of DNA deviates significantly from this assumed quantity. Sequencing results for libraries generated using Nb.BtsI are highly reproducible between different strains (POL, wild-type polymerase; pol1-L868M, increased Pol-α ribonucleotide incorporation) after read counts are normalized to sequence tags per million (TPM). The majority of bona fide Nb.BtsI sites were present at maximal frequency, although some sites were present at lower frequencies. This was the result of partial loss during size selection because of their close proximity to other cleavage sites, which is a highly reproducible finding between independent libraries (Spearman's ρ = 0.82, P < 2.2 × 10 -16 ). Because of star activity, Nb.BtsI-like sites were also detected. Other libraries prepared using BciVI restriction enzyme digestion did not show such star activity (data not shown), and they allowed calculation of the site specificity for the method (>99.9%). (e) Summed signal at Nb.BtsI sites (dark blue, correct strand; light blue, opposite strand) highlights the strand specificity (>99.9%) and single-nucleotide resolution (>99%) of this method. Panels d and e adapted with permission from Reijns et al. 30 .
47| Endonuclease treatment: This should be optimized for each new endonuclease. The following reaction conditions were successfully used for E. coli RNase HII (option A), human RNase H2 (option B; note that alternative sources of type 2 RNase H enzymes may be used) and Nb.BtsI (option C). 
53|
Incubate the library at 95 °C for 5 min in a thermocycler and then snap-cool it in an icy water bath.  crItIcal step Libraries must be denatured immediately before ligation.
54|
Once it is cooled, immediately add 10 µl of 5× buffer, 6 µl of 40 µM dsA adapter and 5 µl of T4 quick ligase from the NEBNext quick ligation module.
55| Incubate the mixture overnight or for at least 12 h at 16 °C.  crItIcal step Ligation for shorter times may be possible, but we have not tested this. 58| Using a magnetic stand to retain the beads, discard the supernatant and replace it with 1 ml of 1× bind and wash buffer.
56|
59|
Using a magnetic stand to retain the beads, discard the supernatant and replace it with 40 µl of 2× bind and wash buffer.
60|
Add the whole 40 µl of adapter-ligated library from
Step 56, and incubate it at RT for 15 min on a rotator.
61|
Using a magnetic stand to retain the beads, discard the supernatant and replace it with 50 µl of saline sodium citrate.
62|
Incubate the mixture at RT for 5 min on a rotator.
63|
Repeat Steps 61 and 62 to ensure that no unbound fragments are carried through.
64|
Using a magnetic stand to retain the beads, discard the supernatant and replace it with 40 µl of 0.15 M NaOH.
65|
Incubate the mixture at RT for 10 min on a rotator.
66|
Using a magnetic stand to retain the beads, transfer the eluate to a new 1.5-ml tube.
67|
Repeat the elution: add 40 µl of 0.15 M NaOH to the beads from Step 66, and incubate the beads at RT for 5 min on a rotator. Using a magnetic stand to retain the beads, collect the eluate and pool it with that collected in Step 66. 
68|
74|
Set up a 2% E-Gel SizeSelect agarose gel on the iBase power system according to the manufacturer's instructions.
75|
Load the library directly into the desired well; loading dye is unnecessary. Use a 100-bp DNA ladder as a marker.
76|
Once the 200-bp fragment has entered the collection well, start collecting the library. Every five seconds, pause the electrophoresis, mix the contents of the well, remove the liquid in the collection well and transfer it to a 1.5-ml collection tube, and replenish the well (20 µl H 2 O). Stop once the 300-bp fragment has completely entered the collection well. A total of ~500 µl is usually collected per sample. Alternatively, the sample can be separated by conventional agarose gel electrophoresis, and fragments between 200 and 300 bp in size can be purified by gel extraction. We have successfully used the QIAquick gel extraction kit (Qiagen, cat. no. 28704) according to the manufacturer's instructions (if this alternative is used, proceed to Step 79).
77|
Assuming that 500 µl has been collected, divide the size-selected DNA into two 250-µl samples in 1.5-ml tubes and ethanol-precipitate it by adding 25 µl of 3 M NaOAc and 700 µl of 100% EtOH. 83| Load 10 µl of each reaction alongside a 100-bp DNA ladder on a 0.5× TBE, 1% agarose gel. Perform electrophoresis and visualize the gel using a nucleic acid stain, allowing for qualitative and semiquantitative assessment. Successfully generated libraries yield a smear between ~200 and 300 bp that is usually visible after 15 cycles of amplification.
78|
? troublesHootInG 84| Using the manufacturer's protocol, confirm the size distribution of the library and estimate its concentration with a bioanalyzer and a high-sensitivity DNA kit (Agilent Technologies).
? troublesHootInG
85|
If the bioanalyzer trace shows a quantifiable distribution of material between ~200 and 300 bp, which can be confirmed by PCR, the library can then be prepared for Ion PGM or Ion Proton sequencing according to the manufacturer's protocol.  crItIcal step The bioanalyzer trace and PCR amplification from a typical library are shown in Figure 2b ,c. The required input for Ion OneTouch emulsion PCR is 100 µl of 12 pM for the Ion Proton and 26 µl of 25 pM for the Ion PGM. We recommend using the Ion PI Chip to achieve the maximum number of reads. Alternatively, the Ion 318 Chip can be used.
bioinformatics • tIMInG variable 86| Align sequence reads to the appropriate genome (we used sacCer3) with Bowtie2 (we used version 2.0.0). Use the following command:
bowtie2 -x sacCer3 -U runName.fastq runName.sam 87| Perform alignment quality filtering and format conversion using Samtools (we used version 0.1.18) and BEDTools (we used version 2.16.2). A Bam file (termed runName.master.bam below) containing all mapped and unmapped reads is a convenient way to store the complete raw sequence and quality information, as well as the alignment to the reference genome. Samtools view with the -q 30 option retains only reads with a mapping quality score of >30 (misalignment probability <0.001) for analysis. The ribonucleotide incorporation site is one nucleotide upstream and on the strand opposite the mapped read 5′ end; this transformation can be achieved with the short Perl code shown below. All command syntaxes shown assume a Bash shell and standard Unix tools in addition to the specific software mentioned above. The commands are as follows: 89| Perform subsequent analysis in the R statistical environment (or Excel) by importing the tab delimited Bed file runName. tmp.bed. Such files can also be loaded into common genome browsers for visualization, and they can be provided as 'processed data files' to the Gene Expression Omnibus (GEO) and similar repositories along with the raw data (fastq file). Steps 86-89, sequencing followed by bioinformatics processing of data: several days Several potential pause points have been highlighted in the protocol. If necessary, it is also possible to pause at many other points. However, it should be noted that AMPure XP beads should be removed before freezing and reintroduced before the next purification step after freezing.
antIcIpateD results
EmRiboSeq libraries generated using this protocol typically had a concentration of 400-2,000 pM. The total number of reads for the Ion 318 Chip was typically four to six million, and for the Ion PI Chip it was an order of magnitude higher, at 50 million to 90 million reads. Of these reads, 70-80% mapped unambiguously (Phred-scaled mapping quality >30) to the yeast genome, which resulted in an average read coverage of >35-fold for the Ion 318 Chip and >400-fold for the PI Chip, with 150 base reads. However, for embedded ribonucleotide mapping, it is the read 5′-end coverage over the genome, rather than sequenced read coverage, that matters. For this measure, 0.2-0.4× genome average coverage for the Ion 318 Chip and 3-6× coverage with the PI Chip were typical. Results for libraries prepared using other endonucleases are likely to be similar, as was the case for control libraries that were prepared using sequence-specific endonucleases. Independent libraries yielded highly reproducible data, and they demonstrated >99.9% site and strand specificity and >99% single-nucleotide resolution (Fig. 2d,e) .
It was previously unknown whether embedded ribonucleotides were randomly distributed throughout the genome. The advent of a number of high-throughput sequencing methods, including emRiboSeq, has started to shed light on this. It is now clear that this distribution is nonrandom, with certain patterns emerging, including those related to polymerase-dependent nucleotide preferences, as well as sequence context 30, [33] [34] [35] . A path is now open for investigating genome-wide ribonucleotide incorporation, uncovering the rules that underlie the observed distribution and determining the (patho)physiological consequences. Additional purification (a further round of AMPure bead purification or spin column-based purification) may help, but it is not guaranteed to improve the trace. N.B. we have successfully generated high-quality sequencing data from samples that failed to produce good bioanalyzer traces. In these cases, we estimated the concentration on the basis of the semiquantitative PCR performed in
Step 82 and compared it with results from a previous library
